BREEZHALER

DEVICE2 trials

Sponsors

GlaxoSmithKline

Conditions

AsthmaPulmonary Disease, Chronic Obstructive

Phase 4

A Comparison of Critical Errors, Overall Errors, Training/Teaching Time, and Preference Attributes of the ELLIPTA Versus BREEZHALER Dry Powder Inhalers (DPIs) in Adult Participants With Asthma

CompletedNCT04813354

GlaxoSmithKlineAsthma

Start: 2021-04-14End: 2021-07-08Updated: 2023-05-15

Unknown Phase

Comparative Study of Error Rates Between ELLIPTA® Dry Powder Inhaler (DPI) and Other DPIs

CompletedNCT03114969

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2017-06-08End: 2018-03-09Updated: 2020-10-28

Related Papers

A randomized, cross-over study comparing critical and overall errors, learning time, and preference of the ELLIPTA versus BREEZHALER dry powder inhalers in patients with asthma.

2022-10-284 citations